mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |